Free shipping on all orders over $ 500

PF-04418948

Cat. No. M9232

All AbMole products are for research use only, cannot be used for human consumption.

PF-04418948 Structure
Size Price Availability Quantity
2mg USD 35 In stock
5mg USD 70 In stock
10mg USD 100 In stock
25mg USD 210 In stock
50mg USD 385 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PF-04418948 inhibited prostaglandin E(2)(PGE(2))-induced increase in cAMP in cells expressing EP(2) receptors with a functional K(B) value of 1.8 nM. In human myometrium, PF-04418948 produced a parallel, rightward shift of the butaprost-induced inhibition of the contractions induced by electrical field stimulation with an apparent K(B) of 5.4 nM. In dog bronchiole and mouse trachea, PF-04418948 produced parallel rightward shifts of the PGE(2)-induced relaxation curve with a K(B) of 2.5 nM and an apparent K(B) of 1.3 nM respectively. Reversal of the PGE(2)-induced relaxation in the mouse trachea by PF-04418948 produced an IC(50) value of 2.7 nM.

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models C57BL/6 mice
Formulation 0.5% methylcellulose, 0.2% Tween 80 in saline
Dosages 10 mg/kg
Administration i.p. or oral gavage
Chemical Information
Molecular Weight 409.41
Formula C23H20FNO5
CAS Number 1078166-57-0
Solubility (25°C) DMSO: ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Erin Greaves, et al. Sci Rep. EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis

[2] Victoria C Jones, et al. Br J Pharmacol. Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2

[3] Birrell MA, et al. Br J Pharmacol. Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.

[4] af Forselles KJ, et al. Br J Pharmacol. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.

Related Prostaglandin Receptor Products
Ethamsylate

Ethamsylate is a haemostatic compound, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.

Tafluprost

Tafluprost is a fluorinated analog of prostaglandin F2-alpha and a PGF2alpha agonist that may be used in glaucoma-related studies.

Terutroban

Terutroban is a selective antagonist of the thromboxane receptor.

Prostaglandin E1

Prostaglandin E1 (Alprostadil) is a prostanoid receptor ligand, which induces vasodilation and inhibits platelet aggregation. Prostaglandin E1 can be used as a vasodilator for the research of peripheral vascular diseases.

Latanoprost

Latanoprost is a prostaglandin F2α analog as well as a prostaglandin-like selective FP receptor agonist with lipophilic and corneal penetrating properties. In addition, Latanoprost also increases ocular fluid outflow, thereby reducing intraocular pressure, and may be used in studies related to glaucoma.

  Catalog
Abmole Inhibitor Catalog




Keywords: PF-04418948 supplier, Prostaglandin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.